PharmaVOICE - 
June 2003
Purchase Issue

In Every Issue
Talent Pool
80 J u n e 20 03 PharmaVOICE Pharma POOL [...]
By
E-Media
76 J u n e 20 03 PharmaVOICE EMEDIA NEW [...]
By
What’s New
PharmaVOICE WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Carbon [...]
By
PharmaTrax
66 J u n e 20 03 PharmaVOICE PHARMA TRAX [...]
By
For Art’s Sake
Creative Review Advertising campaign for Allegra represents an original and [...]
By
PharmaOutlet
The marketplace is fast approaching 100,000 sales representatives, and reports [...]
By

Charles Brennan

PharmaCase
Common to many nonprofits is the develop ment of national [...]
By
Opinions
6 J un e 20 03 PharmaVOICE WHAT’S on your [...]
By
Letter from the Editor
3 PharmaVOICE J un e 2003 PUBLISHER Lisa Banket EDITOR [...]
By

Taren Grom, Editor

On The Cover

Biotech Life-Cycle Management
10 J u n e 20 03 PharmaVOICE THE MANAGEMENTTEAM … CAROLCHERKIS,PH.D. Life sciences consultant,NewCap Partners Inc., Los Angeles; NewCap Partners is a private investment banking firm that focuses on the finance needs of middlemarket companies.For more information, visit newcap.com. TILLMAN U.GERNGROSS,PH.D. Chief scientific officer, GlycoFi Inc., Lebanon,N.H.; GlycoFi is developing technology to address the [...]
By

Elisabeth Pena

Features

An Inquiring Mind: The Pursuit of Knowledge
AN INQUIRING MIND: The Pursuit of Knowledge FROM ACADEMIA TO GOVERNMENT SPONSORED PROGRAMS TOTHE PHARMACEUTICAL INDUSTRY, JONATHANKNOWLES,PH.D., BRINGS TO ROCHE A FOCUSED PERSPECTIVE ONTHE UNIVERSAL POWER OF GOOD SCIENCE,WHICH IS HELPING TO STEER THE COMPANY’S DUAL DIAGNOSTIC AND PHARMACEUTICAL APPROACH TO MEDICINE. BY KIM RIBBINK 51 PharmaVOICE J un e 2 00 3 JONATHAN Knowles [...]
By

Kim Ribbink

How 5/19 Changed the Industry Forever
46 J u n e 20 03 PharmaVOICE n the past two decades, the companies involved in this story have long since changed, casual ties of multiple mergers and acquisitions. But the genesis of DTC advertising can be traced back to Boots Pharmaceuticals, a small Europeanbased pharmaceutical company. While directtophysician ads appeared in print first [...]
By
The Emergence of the Bioscience Cluster
36 J un e 2 003 PharmaVOICE ll drug development is local, to borrow from a popular phrase. Although pharma and biotech companies have to be focused on global issues, they still are firmly rooted in the commu nities in which they reside. State and local governments recognize the benefits to the local economic environment [...]
By

Elisabeth Pena

Striking a Balance for Innovation
26 J u n e 20 03 PharmaVOICE INNOVATION Striking a Balance for BY DENISE MYSHKO Recently proposed regulations strive to restore the balance between protecting the intellectual assets related to innovation by pharmaceutical manufacturers and the opportunity to bring lowercost generic products to market by nonbrand manufacturers. F For hundreds of years, patents protecting [...]
By

Denise Myshko

FEEDBACK